Pentaaza macrocyclic ring complexes possessing oral bioavailability
US9738670B2 · kind B2 · utility
5Cited by
5References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 25, 2016 |
| Grant date | Aug 22, 2017 |
| Priority date | — |
| Expiry date | Aug 25, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Aspects of the present disclosure relate to compounds which have enhanced oral bioavailability. A transition metal complex includes a transition metal coordinated by a macrocycle comprising the pentaaza 15-membered macrocyclic ring corresponding to Formula A and two axial ligands having the formula —OC(O)X1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.